Transporter-mediated drug-drug interactions: regulatory guidelines, <i>in vitro</i> and <i>in vivo</i> methodologies and translation, special populations, and the blood-brain barrier-Reference-Cited by-同舟云学术

Transporter-mediated drug-drug interactions: regulatory guidelines, in vitro and in vivo methodologies and translation, special populations, and the blood-brain barrier

Published:2024-07-05 Issue: Volume: Page:1-28
ISSN:0360-2532
Container-title:Drug Metabolism Reviews
language:en
Short-container-title:Drug Metabolism Reviews

Author:

Russell Laura E.¹^ORCID,Yadav Jaydeep²,Maldonato Benjamin J.³^ORCID,Chien Huan-Chieh⁴^ORCID,Zou Ling⁴,Vergara Ana G.⁵^ORCID,Villavicencio Erick G.⁶^ORCID

Affiliation:

1. Department of Quantitative, Translational, and ADME Sciences, AbbVie Inc, North Chicago, IL, USA

2. Department of Pharmacokinetics, Dynamics, Metabolism, and Bioanalytics, Merck & Co., Inc, Boston, MA, USA

3. Department of Nonclinical Development and Clinical Pharmacology, Revolution Medicines, Inc, Redwood City, CA, USA

4. Department of Pharmacokinetics and Drug Metabolism, Amgen Inc, South San Francisco, CA, USA

5. Department of Pharmacokinetics, Dynamics, Metabolism, and Bioanalytics, Merck & Co., Inc, Rahway, NJ, USA

6. Department of Biology-Discovery, Imaging and Functional Genomics, Merck & Co., Inc, Rahway, NJ, USA

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/03602532.2024.2364591

Reference238 articles.

1. Endogenous gene and protein expression of drug-transporting proteins in cell lines routinely used in drug discovery programs;Ahlin G;Drug Metab Dispos,2009

2. Proteomic Quantification of Human Blood–Brain Barrier SLC and ABC Transporters in Healthy Individuals and Dementia Patients

3. Kidney-specific expression of human organic cation transporter 2 (OCT2/SLC22A2) is regulated by DNA methylation;Aoki M;Am J Physiol-Ren Physiol,2008

4. The blood–brain barrier and blood–tumour barrier in brain tumours and metastases

5. Using Endogenous Biomarkers to Derisk Assessment of Transporter‐Mediated Drug‐Drug Interactions: A Scientific Perspective